BarbeloPodcast Library
hubermanlab
hubermanlab·October 7, 2024

Peptide & Hormone Therapies: Optimizing Health, Performance, and Longevity with Dr. Craig Koniver

Watch on YouTube

Summary

This episode features Dr. Craig Koniver, an expert in performance medicine, discussing the science and clinical application of peptides and other therapies for enhancing mental health, physical health, and overall performance. The conversation introduces peptides as small proteins, distinguishing them from larger proteins, and highlights their diverse roles in the body. Dr. Koniver's expertise lies in the use of exogenous peptides to activate multiple biological pathways, positioning these therapies as a crucial intermediate step between basic lifestyle interventions and more advanced prescription hormone treatments, notably without typically shutting down the body's endogenous production.

A significant portion of the discussion focuses on GLP-1 agonists, such as semaglutide (Ozempic) and tirzepatide (Mounjaro), which have gained widespread attention for weight loss. Initially approved for type 2 diabetes, their weight-reducing side effects led to off-label use and eventual FDA approval for obesity. Dr. Koniver shares his evolving clinical perspective, advocating for microdosing these peptides to achieve gradual weight loss (less than 2 pounds per week), thereby mitigating common side effects like muscle loss and the undesirable "Ozempic face." He emphasizes that successful initial weight loss can serve as a powerful motivator for individuals to adopt broader healthy lifestyle changes, leading to benefits beyond aesthetics, including improved cognitive function and reduced inflammation, even in conditions like Hashimoto's thyroiditis.

The podcast also delves into BPC-157, or Body Protection Compound 157, a peptide widely used for its potent anti-inflammatory and tissue-repairing properties. Dr. Koniver details its utility in treating various conditions, from general inflammation and post-viral issues to specific injuries affecting ligaments and tendons, and even gastrointestinal disorders. He explains that while oral BPC-157 is effective for gut-specific issues, subcutaneous injection offers systemic benefits, suggesting an innate intelligence in the body that directs the peptide to injury sites. The discussion touches on BPC-157's ability to upregulate growth hormone receptors, making it synergistic with growth hormone-releasing peptides.

Further topics include other growth hormone secretagogues like CJC-1295 and Ipamorelin, and Thymosin Beta Alpha, all recently re-approved by the FDA for prescription use, as well as testosterone therapies for both men and women, and NAD. Dr. Koniver also briefly mentions specific supplements he finds useful, such as CoQ10 and methylated B vitamins. The episode underscores the critical importance of safety, ethical sourcing of peptides, and working under the guidance of a board-certified physician when considering these cutting-edge therapies, providing listeners with an up-to-date understanding of this rapidly advancing field.

Key Quotes

"a peptide is simply a small protein so insulin is a peptide we have many different thousands of peptides in our brain and body and they perform a variety of different roles"
"peptide therapies sit somewhere between doing nothing and supplementation and those more advanced hormone therapies and that's why peptide therapies I believe are growing in popularity"
"they can augment specific hormone Pathways they can augment specific in fact multiple processes within the brain and body to augment Health but they don't tend to operate in that negative feedback cycle by shutting down one's own endogenous production"
"most of the medicines prescribed particularly in America are prescribed off label meaning they've never ever been approved for what they're used"
"My Philosophy is I want everyone have to have access to things that are number one safe that propel them to look feel and perform their best"
"if I can help people lose weight first literally by using something like tepati semaglutide and I've seen this they're now excited"
"as long as people are losing less 2 pounds or less a week they're not losing the muscle mass... that micro doing has been a Game-Changer"
"bpc I you know observed with so many patients we're talking thousands upon thousands of patients where their inflammation comes down so they feel better"
"if you're using a growth hormone releasing peptide like semelin or ellin ghrp6 whatever you're helping your pituitary put out more growth hormone well if you combine it with bpc which upregulates the growth hormone receptor you make the process of growth hormon binding more efficient"
"there's a lot you know about our bodies obviously we don't know there's a kind of innate human like design and intelligence which I believe in"

Concepts

Themes

  • Optimizing human health and performance
  • The evolving landscape of medical therapies
  • Balancing therapeutic benefits with safety and side effects
  • Personalized medicine and microdosing
  • The mind-body connection in health outcomes
  • Inflammation and recovery
  • Regulatory challenges and sourcing in novel therapies
  • Metabolic health and its systemic impact

Related to:

Health Insights

Protocols

  • Microdosing GLP-1 agonists (2 lbs/week weight loss limit)
  • BPC-157 dosage (500-5000 mcg/day, 5 days on/2 days off)
  • Subcutaneous injection for systemic effects

Research Cited

  • Animal studies on BPC-157
  • Studies on stem cell migration to injury sites

Actionable Advice

  • Combine GLP-1 agonists with resistance training and adequate protein intake to prevent muscle loss
  • Work with a board-certified physician for peptide use
  • Ensure clean sourcing of peptides

Mechanisms Explained

  • Peptides as small proteins (amino acid chains)
  • GLP-1 agonists' effect on glucose control and satiety
  • BPC-157's anti-inflammatory action and upregulation of growth hormone receptors
  • Growth hormone secretagogues promoting pituitary GH release

Contraindications

  • Rapid weight loss with GLP-1 agonists leading to muscle loss and 'Ozempic face'

Similar Episodes